Testing a blood test to guide antibiotics for lung infections
Part of Infections, Lungs & breathing clinical trials.
This trial studies whether using the MeMed BV® blood test in the emergency room or urgent care can help doctors decide when antibiotics are (or are not) needed for suspected lung infections. It may help reduce unnecessary antibiotics while still treating infections when needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older, and you can (or your guardian can) sign consent.
- Your symptoms started within the last 7 days.
- You have a fever of at least 100°F (37.8°C) OR you felt “feverish” at least once in the last 7 days.
- A clinician thinks you might have a bacterial or viral lower lung infection (new/worsening cough, mucus, shortness of breath, or abnormal lung sounds like wheezing).
- You have not taken systemic antibiotics in the 72 hours before enrollment, and you are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a simple blood test (C-reactive protein, or CRP) and a lung ultrasound to see if they can help doctors tell whether a respiratory infection is likely caused by bacteria. It's for people with a recent cough and other respiratory symptoms who haven't recently taken antibiotics.
This study tests a new way to quickly figure out if a respiratory infection is caused by bacteria or a virus. Knowing this could help doctors choose the right treatment faster and avoid unnecessary antibiotics.
This study tests new diagnostic tools to help quickly identify what's causing your respiratory infection. You'll provide samples (like nasal swabs) to help researchers understand how these new tests work in real patients.
This trial tests whether using a lung ultrasound can help doctors decide if antibiotics are needed for children and teens hospitalized with a lower respiratory tract infection. It may reduce unnecessary antibiotic use.
This trial uses a new blood test (called BV test) to help doctors decide if antibiotics should be stopped or continued for ICU patients with suspected or confirmed infections. It aims to reduce unnecessary antibiotic use while keeping patients safe.
This trial tests an emergency breathing-related approach for adults with a sudden, community-acquired respiratory infection. It may help doctors quickly sort out what’s going on and guide early care.
Hear when a new Lower Respiratory Tract Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.